Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Biomaterials|January 15, 2016
Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeuticKin Man Au, Andrew Satterlee, Yuanzeng Min, et al.
Practical Radiation Oncology|April 29, 2014
Clinical experience with 3-dimensional surface matching-based deep inspiration breath hold for left-sided breast cancer radiation therapyXiaoli Tang, Timothy M Zagar, Eric Bair, et al.
Biochemical Pharmacology|July 17, 2018
Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activationXueyan Zhou, Yun Zhao, Juan Wang, et al.
Nanoscale|November 18, 2015
Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug deliveryXi Tian, Haydee Lara, Kyle T Wagner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2026
MRI-based multilevel radiomics and transformer features for predicting radiation-induced carotid artery injury after nasopharyngeal carcinoma radiotherapy: A multicenter studyHeng Zhang, Jiangyi Ding, Longzhen Zhang, et al.
Biochemical Pharmacology|December 3, 2023
Malonate differentially affects cell survival and confers chemoresistance in cancer cells via the induction of p53-dependent autophagyHao Cui, Bao Zhu, Huiyan Li, et al.
BMC Medicine|January 8, 2023
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa studyYuankai Shi, Jianying Zhou, Yanqiu Zhao, et al.
Nature Nanotechnology|June 27, 2017
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapyYuanzeng Min, Kyle C Roche, Shaomin Tian, et al.
British Journal of Cancer|January 20, 2018
H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastomaWenyan Zhang, Rui Duan, Jian Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2022
Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion StudyYuankai Shi, Yanqiu Zhao, Sheng Yang, et al.
Pageof 10